Allogeneic Mesenchymal Stromal Cell Donor Bank

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 12-008075
    Sponsor Protocol Number: 12-008075

About this study

The purpose of this study is to collect adipose tissue from patients undergoing elective surgery, test the donors to assure that they comply with all regulatory aspects required of healthy donors, expand and test mesenchymal stromal cells (MSC), and bank them for future use.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Healthy donors undergoing elective surgery.
  • Donors greater than or equal to 18 years of age.
  • Either gender.
  • Must meet all tissue donor eligibility criteria.

Exclusion Criteria: 

 

  • Adults lacking capacity, or unwilling to sign informed consent.
  • Any history of therapy or treatment to the abdomen that may affect the fat (i.e., medication injections, Cool Sculpting, other cosmetic procedures, etc.).
  • Any history of malignancy or transplant.
  • Autoimmune disorders.
  • Any antibiotic resistant disease (i.e., MRSA, VRE, etc.).
  • Any chronic infections.
  • Any immunosuppressive medications or biologics.
  • Any long term use of steroid medications.
  • Inflammation of adipose tissue.
  • Any other significant morbidity that in the opinion of the PI would deem the donor ineligible.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Allan Dietz, Ph.D.

Open for enrollment

Contact information:

Karen Krucker

(507)284-2764

Krucker.Karen@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20325798

Mayo Clinic Footer